Methyl Thioglycolate → 3,5-Dichloro-2-fluoro-4-(3-isopropyl-4-hydroxyphenoxy)-6-hydroxycarbonylmethylthiopyridine
Reaktionsgleichung
[SH:1][CH2:2][C:3]([O:5]C)=[O:4].[Cl:7][C:8]1[C:9]([F:33])=[N:10][C:11](NCC(OC)=O)=[C:12]([Cl:26])[C:13]=1[O:14][C:15]1[CH:20]=[CH:19][C:18]([O:21]C)=[C:17]([CH:23]([CH3:25])[CH3:24])[CH:16]=1>>[Cl:7][C:8]1[C:9]([F:33])=[N:10][C:11]([S:1][CH2:2][C:3]([OH:5])=[O:4])=[C:12]([Cl:26])[C:13]=1[O:14][C:15]1[CH:20]=[CH:19][C:18]([OH:21])=[C:17]([CH:23]([CH3:25])[CH3:24])[CH:16]=1Komponenten
3
Versuchsvorschrift
By use of methyl mercaptoacetate in place of glycine methyl ester for the preparation of Compound 1e followed by deprotection as described for example 2.
Quellen und Nachweise
- ORD-Eintrag
- ord-e100dd874c334c338dd1ada760046b2f
- Quelldatensatz
- uspto-grants-2004_06
- DOI